Analysts expect that MAXIMUS, Inc. (NYSE:MMS) will announce $0.77 earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Five analysts have made estimates for MAXIMUS’s earnings, with the lowest EPS estimate coming in at $0.75 and the highest estimate coming in at $0.79. MAXIMUS reported earnings per share of $0.71 in the same quarter last year, which suggests a positive year-over-year growth rate of 8.5%. The company is scheduled to report its next earnings report on Thursday, February 8th.

On average, analysts expect that MAXIMUS will report full year earnings of $3.05 per share for the current financial year, with EPS estimates ranging from $3.00 to $3.11. For the next financial year, analysts anticipate that the company will post earnings of $3.33 per share, with EPS estimates ranging from $3.28 to $3.40. Zacks Investment Research’s EPS averages are an average based on a survey of sell-side research analysts that follow MAXIMUS.

MAXIMUS (NYSE:MMS) last announced its quarterly earnings data on Thursday, November 9th. The health services provider reported $0.81 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.77 by $0.04. MAXIMUS had a return on equity of 23.97% and a net margin of 8.54%.

A number of brokerages recently weighed in on MMS. Zacks Investment Research raised MAXIMUS from a “sell” rating to a “hold” rating in a report on Wednesday. Canaccord Genuity reaffirmed a “buy” rating on shares of MAXIMUS in a report on Wednesday, December 27th. One analyst has rated the stock with a sell rating, five have issued a hold rating and one has assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average target price of $65.60.

In other MAXIMUS news, insider Mark Andrekovich sold 2,700 shares of the business’s stock in a transaction on Friday, December 15th. The stock was sold at an average price of $72.00, for a total transaction of $194,400.00. Following the sale, the insider now directly owns 20,296 shares in the company, valued at $1,461,312. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Russell A. Beliveau sold 1,000 shares of the business’s stock in a transaction on Tuesday, January 2nd. The stock was sold at an average price of $71.73, for a total value of $71,730.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 71,417 shares of company stock worth $4,902,785. 3.10% of the stock is owned by company insiders.

A number of institutional investors and hedge funds have recently bought and sold shares of MMS. JPMorgan Chase & Co. boosted its position in MAXIMUS by 459.2% during the second quarter. JPMorgan Chase & Co. now owns 25,842 shares of the health services provider’s stock worth $1,619,000 after purchasing an additional 21,221 shares in the last quarter. Alliancebernstein L.P. lifted its position in shares of MAXIMUS by 30.8% in the second quarter. Alliancebernstein L.P. now owns 146,431 shares of the health services provider’s stock valued at $9,171,000 after acquiring an additional 34,470 shares in the last quarter. Martingale Asset Management L P purchased a new stake in shares of MAXIMUS in the second quarter valued at $1,191,000. Riverhead Capital Management LLC lifted its position in shares of MAXIMUS by 72.6% in the second quarter. Riverhead Capital Management LLC now owns 4,661 shares of the health services provider’s stock valued at $292,000 after acquiring an additional 1,961 shares in the last quarter. Finally, Teachers Advisors LLC lifted its position in shares of MAXIMUS by 4.1% in the second quarter. Teachers Advisors LLC now owns 124,853 shares of the health services provider’s stock valued at $7,820,000 after acquiring an additional 4,886 shares in the last quarter. Institutional investors own 94.79% of the company’s stock.

Shares of MAXIMUS (NYSE MMS) traded up $0.51 during mid-day trading on Friday, reaching $70.09. The company had a trading volume of 614,838 shares, compared to its average volume of 316,889. MAXIMUS has a 52-week low of $51.74 and a 52-week high of $72.71. The firm has a market capitalization of $4,532.20, a price-to-earnings ratio of 22.04, a PEG ratio of 2.61 and a beta of 1.34.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, February 28th. Shareholders of record on Thursday, February 15th will be given a dividend of $0.045 per share. The ex-dividend date of this dividend is Wednesday, February 14th. This represents a $0.18 dividend on an annualized basis and a yield of 0.26%. MAXIMUS’s payout ratio is 5.66%.

ILLEGAL ACTIVITY WARNING: This story was originally published by American Banking News and is owned by of American Banking News. If you are viewing this story on another domain, it was illegally copied and republished in violation of US and international copyright and trademark law. The legal version of this story can be accessed at https://www.americanbankingnews.com/2018/01/20/analysts-anticipate-maximus-inc-mms-to-announce-0-77-earnings-per-share.html.

About MAXIMUS

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Get a free copy of the Zacks research report on MAXIMUS (MMS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.